Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cancer Immunotherapy - "B7.1 Gene Transfer in Cancer Cells Protects Cytotoxic T Cells From Deletion by Apoptosis."
Cancer Immunotherapy - "DNA Vaccines Targeting Dendritic Cells for the Immunotherapy of Cancer."
Cancer Immunotherapy - "Different Approaches for IL-4 Gene Transfer Can Be Effective in the Treatment of Experimental Gliomas."
Cancer Immunotherapy - "Hybrid Cell Vaccination in Cancer Immunotherapy: Recruitment and Activation of T Cell Help for Induction of Anti Tumour Cytotoxic T Cells."
Cancer Vaccines - "Induction of Anti-Tumor Immunity by Targeting Soluble Recombinant B7-2-IgG3 Costimulatory Molecule Onto Murine Tumors."
Cancer Vaccines - "Induction of Tumour Rejection By B7.1 and IL-2 Expressing Tumour Cells."
Diagnostics (Metastasis) - "Detection of Micrometastasis in 31 Patients with Breast Cancer by RT-PCR and Immunomagnetic Separation (ISM) Techniques."
Therapy (Fungal Infections) - "G-CSF Mobilized White Cells Transfusions in the Treatment of Refractory Fungal Infections in Neutropenic Patients."
Breast Cancer - "Expression of Transforming Growth Factor beta Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells."
Breast Cancer - "Time Since Childbirth and Prognosis in Primary Breast Cancer: Population Based Study."
Breast Cancer - "Translational Research Studies of erbB Oncogenes: Selection Strategies for Breast Cancer Treatment."
Cancer Gene Therapy - "Induction of Antigen-Specific Antitumor Immunity with Adenovirus-Transduced Dendritic Cells."
Cancer Gene Therapy - "Interferon-alpha Gene Therapy for Cancer: Retroviral Transduction of Fibroblasts and Particle-Mediated Transfection of Tumor Cells Are Both Effective Strategies for Gene Delivery in Murine Tumor Models. DOUBLEQUO
Cancer Gene Therapy - "Spontaneous But Not Experimental Metastatic Activities Differentiate Primary Tumor-Derived vs. Metastasis-Derived Mouse Prostate Cancer Cell Lines."
Cancer Gene Therapy - "Virally Directed Cytosine Deaminase/5-fluorocytosine Gene Therapy Enhances Radiation Response in Human Cancer Xenografts."
Colorectal Cancer - "Colorectal Cancer Mass-Screening: Estimation of Faecal Occult Blood Test Sensitivity, Taking into Account Cancer Mean Sojourn Time."
Colorectal Cancer - "Effect of Faecal Occult Blood Testing on Colorectal Mortality: Results of a Population-Based Case-Control Study in the District of Florence, Italy."
Genetics - "Telomeric Association in Women with Breast and Uterine Cervix Cancer."
Hepatocellular Carcinoma (HCV) - "Natural History of Advanced Hepatocellular Carcinoma in Crete. Association with Hepatitis C Virus."
Liposomes - "Anti-HER2 Immunoliposomes for Targeted Therapy of Human Tumors."
Liver Cancer - "Diabetes Mellitus and the Risk of Primary Liver Cancer."
Melanoma - "Double-Copy Bicistronic Retroviral Vector Platform for Gene Therapy and Tissue Engineering: Application to Melanoma Vaccine Development."
Melanoma - "Synthetic Peptides Derived from the Melanocyte-Stimulating Hormone Receptor MC1R Can Stimulate HLA-A2-Restricted Cytotoxic T Lymphocytes That Recognize Naturally Processed Peptides on Human Melanoma Cells. DOUBLEQU
Monoclonal Antibodies - "Local But No Systemic Immunomodulation by Intraperitoneal Treatment of Advanced Ovarian Cancer with Autologous T Lymphocytes Re-Targeted by a Bi-Specific Monoclonal Antibody."
Ovarian Cancer - "Increased Matrix Metalloproteinase-9 Activity in Human Ovarian Cancer Cells Cultured with Conditioned Medium from Human Peritoneal Tissue."
Prostate Cancer - "Inhibition of Osteoblastic Cell Differentiation by Conditioned Medium Derived from the Human Prostatic Cancer Cell Line PC-3 in vitro."
